A research center newly created by the University of California, Berkeley, and Lawrence Berkeley National Laboratory (LBNL) aims to put light-sensitive switches in the body’s cells that can be flipped on and off as easily as a remote control operates a TV. Optical switches like these could trigger a chemical reaction, initiate a muscle contraction, activate a drug or stimulate a nerve cell – all at the flash of a light.
The high-stakes task of designing new drugs relies on high-tech tools, especially computerized, three-dimensional simulations of proteins. Researchers at the San Diego Supercomputer Center (SDSC), contributing their massive computational capabilities to a collaboration with colleagues at the University of Washington (UW) and IBM, have helped to achieve the largest-ever protein-structure prediction – and completed the complex simulation in less than three hours.
Berlex Oncology, a business unit of Berlex Laboratories, a U.S. affiliate of Schering AG, Germany (FSE: SCH; NYSE: SHR), today announced that a national clinical study is underway investigating a new approach to treating follicular B-cell lymphoma, a sub-type of non-Hodgkin?s lymphoma (NHL). NHL is the fifth most common form of cancer in the United States, with more than 56,000 new cases diagnosed each year. Follicular B-cell lymphoma is an indolent, or slow-growing, type of NHL that comprises approximately 30% of all diagnosed cases.
Ethnic pride can help teenagers maintain happiness when faced with stress, according to a new study by a Wake Forest University psychologist published in the October issue of Child Development. Adolescents with positive feelings toward their ethnic group say they are happier on a daily basis than those who have a more negative attitude about their ethnic identity, said Lisa Kiang, assistant professor of psychology at Wake Forest and lead author of the study.
Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients. In a study published in this week’s issue of the Proceedings of the National Academy of Sciences, the gene, called uPAR, offers a promising target for therapeutic drugs to stop or slow the progression of the disease and could serve as a screening tool for assessing which types of drugs a patient will respond to.
In the case of an outbreak of pandemic flu, large majority of Americans willing to make major changes in their lives. Survey also finds many people would face critical work-related problems. The latest national survey conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that when faced with a serious outbreak of pandemic flu, a large majority of Americans are willing to make major changes in their lives and cooperate with public health officials’ recommendations.
Harvard School of Public Health (HSPH) has awarded its highest honor, for the promotion of high public health standards among vulnerable populations, to William H. Foege, former Director of the U.S. Centers for Disease Control and a founder of the Task Force for Child Survival and Development, and Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID). The two recipients have dedicated their lives to protecting people in this country and throughout the world from infectious diseases.
The King’s Centre for Military Health Research (KCMHR) has received further funding from the UK Ministry of Defence to continue its research into the health and well-being of military personnel, many of whom have served in Iraq. The research, which began in 2003 as a prospective investigation of the physical and psychological health of over 12,000 UK service personnel serving in Iraq, will be monitoring service personnel more widely, including those deployed to Afghanistan.
The first human Alzheimer’s vaccine trial in the UK is being resurrected in a study launched by the Alzheimer?s Research Trust. The charity hopes it will indicate whether immunisation against Alzheimer’s is an effective method of tackling the disease.
Proteins found in the blood can indicate an increased risk of Alzheimer’s disease, according to groundbreaking new research published today (30 October) in the journal Brain. It is the first time markers for the development of Alzheimer’s have been identified in blood. The findings take researchers a step closer to knowing whether a blood test can be used to diagnose and measure progression of the Alzheimer’s disease.